As of July 21, 2020, 338 million doses of the COVID-19 vaccine have been given out. To date, the only way to record and verify these immunizations is through a paper vaccination card provided by the CDC. These vaccine cards may need to be used at schools, businesses, healthcare settings, during international travel or air travel, and more. There is a need for an easy-to-use tool or record of vaccination proof outside of the paper vaccination card.
VaxAssist is a mobile patient vaccination portal designed with users to help users track their records, remind them about upcoming appointments, log their symptoms, and check their COVID-19 test results all through a secure blockchain network. VaxAssist can send users push notifications regarding the latest updates about COVID-19, boosters, and any other company news through partnerships with pharmaceutical companies.
The Serviceable Obtainable Market (SOM) is $850 M calculated from the bottom-up. After entry into the vaccine passport market, the app can focus on further market expansion and application into electronic health record systems and IT systems in healthcare lead to a TAM of $185 B.
Competition on the market includes several independently owned vaccine passport apps as well as government-funded applications. However, none of these have functionality past just a vaccine passport. Additionally, VaxAssist is the only application that will secure patient data using blockchain encryption.
VaxAssist plans to partner with big-name pharmaceutical companies like Pfizer, Johnson & Johnson, Eli Lilly, and others by offering anonymized data about symptom tracking and vaccine usage at $0.50 per user per month. In return, these companies can rely on VaxAssist to push notifications about updates like boosters, flu shots, and more.
Marketing and Sales
Marketing to pharmaceuticals will focus on conferences and events to market the app in person. User targeted marketing will use ad campaigns, and email newsletters to raise awareness of VaxAssist
Progress to Date
Currently, we have a working prototype using the online application Figma.
4-6 months: App version 1.0 release and pharmaceutical partnerships established 1 year: Cross-platform development and target of 500,000 users 1.5 years: Expanded to full medical records, licensing to professional healthcare settings